Laporan Laba Rugi 002275 - TTM - Guilin Sanjin Pharmaceutical Co., Ltd.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Guilin Sanjin Pharmaceutical Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2022 01-01	2022 03-31	2022 06-30	2022 09-30	2023 01-01	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31
Revenue	1,611	1,566	1,667	1,694	1,724	1,741	1,829	1,857	1,925	1,960	2,159	2,158	2,153	2,172	1,938	2,046	2,115	2,194	2,178
Change (%)		-2.76	6.44	1.60	1.78	0.98	5.01	1.55	3.65	1.83	10.16	-0.02	-0.27	0.89	-10.74	5.55	3.36	3.75	-0.73
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	448	449	491	510	510	457	458	463	487	574	625	618	609	603	547	553	568	610	590
Change (%)		0.23	9.18	3.87	0.01	-10.30	0.28	1.05	5.15	17.94	8.84	-1.19	-1.47	-0.99	-9.23	1.18	2.56	7.57	-3.37
% of Revenue	27.82	28.68	29.42	30.07	29.55	26.25	25.07	24.94	25.31	29.31	28.96	28.62	28.27	27.75	28.22	27.05	26.84	27.82	27.09

Gross Operating Profit	1,163	1,117	1,177	1,185	1,215	1,284	1,370	1,394	1,438	1,385	1,534	1,541	1,544	1,569	1,391	1,492	1,547	1,584	1,588
Change (%)		-3.91	5.34	0.66	2.54	5.72	6.70	1.71	3.15	-3.63	10.70	0.46	0.21	1.63	-11.32	7.27	3.66	2.36	0.29
% of Revenue	72.18	71.32	70.58	69.93	70.45	73.75	74.93	75.06	74.69	70.69	71.04	71.38	71.73	72.25	71.78	72.95	73.16	72.18	72.91

SG&A	592	626	651	670	721	723	765	775	822	817	897	902	912	921	874	913	907	897	891
Change (%)		5.66	3.95	2.90	7.70	0.32	5.70	1.32	6.07	-0.63	9.90	0.55	1.06	0.96	-5.10	4.48	-0.59	-1.10	-0.69
% of Revenue	36.78	39.96	39.02	39.52	41.82	41.55	41.82	41.72	42.70	41.67	41.57	41.81	42.36	42.40	45.08	44.62	42.91	40.91	40.92

R&D	153	148	158	185	208	202	209	178	159	217	220	203	195	158	118	173	168	173	179
Change (%)		-3.32	7.28	16.60	12.45	-2.88	3.59	-14.77	-10.52	36.28	1.43	-7.84	-3.88	-18.94	-25.35	46.47	-3.03	3.41	3.04
% of Revenue	9.47	9.42	9.49	10.90	12.04	11.58	11.42	9.59	8.28	11.07	10.20	9.40	9.06	7.28	6.09	8.45	7.92	7.90	8.20

OpEx	1,191	1,253	1,333	1,392	1,475	1,415	1,462	1,447	1,491	1,644	1,780	1,758	1,749	1,711	1,564	1,676	1,690	1,714	1,701
Change (%)		5.21	6.33	4.45	5.95	-4.06	3.36	-1.02	3.02	10.26	8.28	-1.27	-0.47	-2.18	-8.60	7.19	0.82	1.38	-0.72
% of Revenue	73.94	80.00	79.91	82.16	85.52	81.26	79.97	77.95	77.48	83.89	82.46	81.43	81.27	78.80	80.69	81.94	79.93	78.10	78.11

Operating Income	420	313	335	302	250	326	366	409	433	316	379	401	403	460	374	369	425	480	477
Change (%)		-25.37	6.89	-9.73	-17.43	30.75	12.20	11.80	5.86	-27.16	19.92	5.89	0.60	14.18	-18.71	-1.29	14.90	13.18	-0.77
% of Revenue	26.06	20.00	20.09	17.84	14.48	18.74	20.03	22.05	22.52	16.11	17.54	18.57	18.73	21.20	19.31	18.06	20.07	21.90	21.89

Interest Expense	-6	-12	-12	-13	-17	-18	-17	-36	-17	-20	-27	-2	-33	-16	-9	-18		-14	-15
Change (%)		102.56	2.28	13.47	28.89	5.36	-6.43	111.31	-51.77	16.52	35.58	-93.14	1,677.51	-51.09	-47.97	107.62			10.77
% of Revenue	-0.35	-0.74	-0.71	-0.79	-1.00	-1.05	-0.93	-1.94	-0.90	-1.03	-1.27	-0.09	-1.55	-0.75	-0.44	-0.86		-0.63	-0.70

Net Income	367	277	298	283	265	344	366	399	375	330	379	406	402	421	352	343	408	522	526
Change (%)		-24.42	7.54	-5.02	-6.39	29.76	6.51	9.11	-6.07	-12.17	14.92	7.25	-1.01	4.79	-16.43	-2.66	19.13	27.74	0.92
% of Revenue	22.75	17.68	17.87	16.70	15.36	19.74	20.02	21.51	19.50	16.81	17.54	18.82	18.68	19.40	18.17	16.75	19.31	23.77	24.17

Source: Capital IQ

Guilin Sanjin Pharmaceutical Co., Ltd. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)